PL3229792T3 - Kompozycja do łagodzenia suchości w jamie ustnej - Google Patents

Kompozycja do łagodzenia suchości w jamie ustnej

Info

Publication number
PL3229792T3
PL3229792T3 PL15867121.4T PL15867121T PL3229792T3 PL 3229792 T3 PL3229792 T3 PL 3229792T3 PL 15867121 T PL15867121 T PL 15867121T PL 3229792 T3 PL3229792 T3 PL 3229792T3
Authority
PL
Poland
Prior art keywords
relief
composition
dry mouth
mouth
dry
Prior art date
Application number
PL15867121.4T
Other languages
English (en)
Polish (pl)
Inventor
Jerome E. Swanson
Original Assignee
Elevate Oral Care, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elevate Oral Care, Llc filed Critical Elevate Oral Care, Llc
Publication of PL3229792T3 publication Critical patent/PL3229792T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • A61K31/78Polymers containing oxygen of acrylic acid or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/547Chelates, e.g. Gd-DOTA or Zinc-amino acid chelates; Chelate-forming compounds, e.g. DOTA or ethylenediamine being covalently linked or complexed to the pharmacologically- or therapeutically-active agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PL15867121.4T 2014-12-10 2015-11-20 Kompozycja do łagodzenia suchości w jamie ustnej PL3229792T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462089942P 2014-12-10 2014-12-10
PCT/US2015/061743 WO2016094054A1 (en) 2014-12-10 2015-11-20 Composition for the relief of dry mouth

Publications (1)

Publication Number Publication Date
PL3229792T3 true PL3229792T3 (pl) 2024-06-10

Family

ID=56107939

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15867121.4T PL3229792T3 (pl) 2014-12-10 2015-11-20 Kompozycja do łagodzenia suchości w jamie ustnej

Country Status (9)

Country Link
US (1) US10772908B2 (enExample)
EP (1) EP3229792B1 (enExample)
JP (1) JP6783244B2 (enExample)
AU (1) AU2015361122B2 (enExample)
CA (1) CA2970146C (enExample)
ES (1) ES2982077T3 (enExample)
MX (1) MX388182B (enExample)
PL (1) PL3229792T3 (enExample)
WO (1) WO2016094054A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190015529A1 (en) 2016-01-10 2019-01-17 Smilesonica Inc. Viscosity and stability modified ultrasound gel
CN105833278B (zh) * 2016-04-25 2018-05-08 北京嘉安医疗器械科技有限公司 用于治疗口腔干燥和口腔疾病的组合物
CA3054654A1 (en) 2017-02-22 2018-08-30 Smilesonica Inc. Artificial saliva, related methods, and uses
CA3195741A1 (en) * 2020-10-15 2022-04-21 Peter M. Milgrom A thickened silver diamine fluoride composition

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3970747A (en) * 1974-03-11 1976-07-20 Colgate-Palmolive Company Humectant sweetener
US4340583A (en) * 1979-05-23 1982-07-20 J. M. Huber Corporation High fluoride compatibility dentifrice abrasives and compositions
US4997654A (en) * 1989-08-14 1991-03-05 Warner-Lambert Company Method for increasing salivation for xerostomia patients
US5496558A (en) * 1993-03-02 1996-03-05 Block Drug Company Inc. Solid form xerostomia product
US5900230A (en) 1997-08-18 1999-05-04 Squigle, Inc. Dental products to treat and prevent periodontal disease
EP1068871A1 (en) * 1999-07-07 2001-01-17 Jean-Paul Perraudin Novel methods and medicament for treating infections diseases involving microbial biofilms
ATE466566T1 (de) 2004-08-02 2010-05-15 Glaxo Group Ltd Neue zusammensetzung gegen xerostomie
WO2009108713A2 (en) * 2008-02-25 2009-09-03 Signum Biosciences, Inc. Topical compositions and methods utilizing peptides containing lipid-modified cysteine-containing peptides
US8735374B2 (en) 2009-07-31 2014-05-27 Intelgenx Corp. Oral mucoadhesive dosage form
JP5433355B2 (ja) * 2009-09-16 2014-03-05 サンスター株式会社 口腔用組成物
US8658139B1 (en) * 2010-02-27 2014-02-25 Squigle, Inc. Prevention and treatment of oral diseases
WO2011130009A1 (en) 2010-04-14 2011-10-20 Isp Investments Inc. Oral care compositions
WO2011162756A1 (en) 2010-06-23 2011-12-29 Colgate-Palmolive Company Therapeutic oral composition
US20120053130A1 (en) * 2010-08-30 2012-03-01 Bristol-Myers Squibb Company Composition for enhancing absorption of a drug and method
JP6143675B2 (ja) 2010-12-16 2017-06-07 セルジーン コーポレイション 難溶性薬物の制御放出経口剤形及びその使用
SG190974A1 (en) 2010-12-23 2013-07-31 Colgate Palmolive Co Aqueous oral care composition comprising xanthan gum, cellulose gum and carbomer
LT2758037T (lt) 2011-09-23 2018-06-25 Emerald Hilton Davis, Llc Savitvarkė nanostruktūros dalelė ir jos gavimo būdas
AU2011383326B2 (en) * 2011-12-15 2016-01-28 Colgate-Palmolive Company Aqueous oral care compositions
US9724542B2 (en) 2012-10-12 2017-08-08 Premier Dental Products Company Remineralizing and desensitizing compositions, treatments and methods of manufacture

Also Published As

Publication number Publication date
AU2015361122B2 (en) 2020-12-17
US10772908B2 (en) 2020-09-15
US20170354676A1 (en) 2017-12-14
EP3229792A1 (en) 2017-10-18
EP3229792A4 (en) 2018-08-08
ES2982077T3 (es) 2024-10-14
EP3229792B1 (en) 2024-02-07
EP3229792C0 (en) 2024-02-07
AU2015361122A1 (en) 2017-06-22
JP2017537983A (ja) 2017-12-21
CA2970146C (en) 2023-10-31
CA2970146A1 (en) 2016-06-16
MX2017007597A (es) 2018-03-01
MX388182B (es) 2025-03-19
JP6783244B2 (ja) 2020-11-11
WO2016094054A1 (en) 2016-06-16

Similar Documents

Publication Publication Date Title
ZA201702202B (en) Capsule composition
PL3685682T3 (pl) Doustna kompozycja nawadniająca
GB201501859D0 (en) Composition
GB201410905D0 (en) Composition
SG11201704735WA (en) Composition
SG11201702700UA (en) Methods for the treatment of peri-implantitis
ZA201704464B (en) Composition
GB201403017D0 (en) Composition
GB201408167D0 (en) Compositions
PL3229792T3 (pl) Kompozycja do łagodzenia suchości w jamie ustnej
GB201414910D0 (en) Composition
GB201403561D0 (en) Composition
SI3217964T1 (sl) Sestavek
PT3125859T (pt) Composição filmogénia
GB201414555D0 (en) Composition
SG11201610547WA (en) Solid composition
GB201410493D0 (en) Composition
IL249151B (en) A preparation for oral administration
GB201519442D0 (en) Composition
ZA201606127B (en) Composition
GB201420628D0 (en) Composition
GB201415483D0 (en) Composition
GB201404390D0 (en) Composition
GB201402648D0 (en) Composition
IL250781A0 (en) preparation